UG - United-Guardian, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

United-Guardian, Inc.

230 Marcus Boulevard
Hauppauge, NY 11788
United States
631-273-0900
http://www.u-g.com

SectorConsumer Goods
IndustryPersonal Products
Full Time Employees29

Key Executives

NameTitlePayExercisedAge
Mr. Kenneth H. GlobusChairman, Chief Exec. Officer, Pres and Gen. Counsel387.7kN/A65
Mr. Robert S. RubingerChief Financial Officer, Exec. VP, Treasurer, Sec. and Director216.31kN/A74
Mr. Joseph J. VerniceVP220.96kN/A59
Roseann LaCorteController and Accounting Mang.N/AN/A50
Mr. Peter A. HiltunenVP and Production Mang.N/AN/A58
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

United-Guardian, Inc. researches, develops, manufactures, and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products, and specialty industrial products in the United States, China, Canada, and internationally. It offers personal care products, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics; LUBRASLIDE and B-122 powdered lubricants for use in the manufacture of cosmetics, such as pressed powders, eyeliners, and rouges; KLENSOFT, a surfactant for use in shampoos, shower gels, makeup removers, and other cosmetic formulations; and LUBRASIL, a special form of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base. The company’s medical products comprise LUBRAJEL RR and RC lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC for oral use; LUBRAJEL FLUID to lubricate water-soluble products; LUBRAJEL BA for oral care; and LUBRAJEL TF, a medical lubricant for medical products companies. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder. The company’s industrial products include DESELEX liquid, a sequestering and chelating agent that is a replacement for phosphates in the manufacture of detergents; and THOROCLENS, a chlorine-based cleanser. It markets its products through marketing partners and distributors, advertising in medical and trade journals, mailings to physicians and to the trade, and exhibitions at medical meetings. The company was founded in 1942 and is based in Hauppauge, New York.

Corporate Governance

United-Guardian, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.